NVO - Novo Nordisk A/S
NYSE - NYSE Delayed Price. Currency in USD
Currency in USD
Valuation measures4
| Market cap (intra-day) | 359.85B |
| Enterprise value | 359.52B |
| Trailing P/E | 40.70 |
| Forward P/E | 31.95 |
| PEG Ratio (5 yr expected) | 1.68 |
| Price/sales (ttm) | 13.22 |
| Price/book (mrq) | 30.58 |
| Enterprise value/revenue | 1.91 |
| Enterprise value/EBITDA | 4.31 |
Trading information
Stock price history
| Beta (5Y monthly) | 0.31 |
| 52-week change 3 | 40.12% |
| S&P500 52-week change 3 | 3.90% |
| 52-week high 3 | 172.97 |
| 52-week low 3 | 95.02 |
| 50-day moving average 3 | 163.85 |
| 200-day moving average 3 | 133.01 |
Share statistics
| Avg vol (3-month) 3 | 1.45M |
| Avg vol (10-day) 3 | 1.63M |
| Shares outstanding 5 | 2.24B |
| Implied shares outstanding 6 | N/A |
| Float 8 | 12.9B |
| % held by insiders 1 | 0.01% |
| % held by institutions 1 | 8.61% |
| Shares short (14 May 2023) 4 | 1.56M |
| Short ratio (14 May 2023) 4 | 1.13 |
| Short % of float (14 May 2023) 4 | N/A |
| Short % of shares outstanding (14 May 2023) 4 | 0.07% |
| Shares short (prior month 13 Apr 2023) 4 | 1.72M |
Dividends & splits
| Forward annual dividend rate 4 | 1.76 |
| Forward annual dividend yield 4 | 1.11% |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | 1.90 |
| Payout ratio 4 | 45.75% |
| Dividend date 3 | 03 Apr 2023 |
| Ex-dividend date 4 | 23 Mar 2023 |
| Last split factor 2 | 5:1 |
| Last split date 3 | 08 Jan 2014 |
Financial highlights
Currency in DKK.Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 30 Mar 2023 |
Profitability
| Profit margin | 32.46% |
| Operating margin (ttm) | 43.27% |
Management effectiveness
| Return on assets (ttm) | 22.78% |
| Return on equity (ttm) | 83.50% |
Income statement
| Revenue (ttm) | 188.29B |
| Revenue per share (ttm) | 10.42 |
| Quarterly revenue growth (yoy) | 27.00% |
| Gross profit (ttm) | 148.51B |
| EBITDA | 86.86B |
| Net income avi to common (ttm) | 61.13B |
| Diluted EPS (ttm) | 3.89 |
| Quarterly earnings growth (yoy) | 39.40% |
Balance sheet
| Total cash (mrq) | 27.77B |
| Total cash per share (mrq) | 1.54 |
| Total debt (mrq) | 25.52B |
| Total debt/equity (mrq) | 31.95 |
| Current ratio (mrq) | 0.86 |
| Book value per share (mrq) | 4.44 |
Cash flow statement
| Operating cash flow (ttm) | 85.12B |
| Levered free cash flow (ttm) | 57.8B |
© 2023 Yahoo. All rights reserved.